医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

New Pharmacy Benefit Management Company RxAdvance Expands Executive Management Team

2013年08月16日 PM09:25
このエントリーをはてなブックマークに追加


 

SOUTHBOROUGH, Mass.

RxAdvance, an innovative pharmacy benefit management (PBM) company, has expanded its executive management team with industry veterans Prakash Tallabattula, who joins as executive vice president and chief technology officer; Frank Shiraldi, who will serve as executive vice president and chief pharmacy officer; and Christine Kyle, who will be executive vice president and chief marketing officer.

RxAdvance was established by Ravi Ika, founder and executive chairman of Southborough-based ikaSystems until this past February. Ika has proven that significant administrative cost reductions were possible with a cloud-based technology platform. He very quickly raised funding for and launched RxAdvance, bringing his same “game-changing” approach to the pharmacy benefit management industry. In his latest endeavor, Ika has created an actual full service PBM company to run efficiently through technology innovation. This innovation will significantly reduce RxAdvance’s administrative costs and plan sponsor unit costs; optimize drug utilization/adherence; and improve collaboration and transparency between plan sponsors and RxAdvance for better health outcomes.

Prakash Tallabattula, executive vice president and chief technology officer, oversees all technology operations, research and development, both onshore and offshore. Tallabattula is an effective leader and hands-on technology strategist with over 15 years of documented achievements in start-up, turnaround, high-growth, and Fortune 500 corporate environments. He is a driving force behind innovative strategies, processes, and technology solutions delivered collaboratively through strong cross-functional relationships built across the organization.

Prior to joining RxAdvance, Tallabattula worked as a senior enterprise architect at Fannie Mae, where he was responsible for the organization’s technology roadmap. He was also a senior architect at Verizon, where he played a key technical role on Verizon Dialup/DSL/FIOS solutions. In addition, he headed technology teams and was a member of executive teams at Sylvan Learning, Hanleywood, and other companies.

Frank Schiraldi, R.Ph., executive vice president and chief pharmacy officer, is responsible for development, implementation and oversight of the PBM program across multiple business lines. He ensures compliance with contractual guidelines affected by regulatory agencies, and leads strategic approaches to managing pharmacy costs for health plans that include sophisticated modeling. Schiraldi also oversees the drug utilization committee, plan-specific pharmacy management initiatives, and strategic pharmacy network contracting. He is a member of the Pharmacy and Therapeutics Committee.

Schiraldi most recently served as vice president of business informatics at BeneCard PBF, where he was responsible for operational metrics for key business areas across the company, including clinical services, client services, networks, sales, and the executive management team. Before that, he served as vice president at Xerox Audit & Compliance Solutions, where he oversaw a pharmacy auditing company and developed advanced pharmacy claims analytical tools and fraud detection methodology. He held positions with McKesson and Rite Aid Corporation, with responsibilities in third-party administration and management. He has also held various business and clinical roles with companies including Keystone Mercy Health Plan and Eagle Managed Care.

Christine Kyle, executive vice president and chief marketing officer, is responsible for overall sales and marketing activities for all lines of business of the company. She is also responsible for strategic business development and partnership development. Most recently, Kyle served as the vice president of sales for Sodexo, a global healthcare onsite service solutions company providing strategic direction and sales leadership for the company’s U.S. senior living division. Previously, she was vice president of specialty pharmacy payer sales and account services for CVS Caremark where she was responsible for providing strategic direction to support the market development of existing clients and expand into new and competitive markets. Prior to that, Kyle was vice president at Aetna specialty pharmacy sales and account management. She has held respected positions at the top five Fortune 100 health insurance companies (Aetna, Humana, Anthem BCBS, UnitedHealthcare and Cigna) and is an expert in her field. Her inherent knowledge of the industry and strong leadership skills have contributed to her high degree of success in management, strategic planning, and business development.

About RxAdvance
RxAdvance is a pharmacy benefit management (PBM) company created specifically for the future of healthcare. We are a single resource to help you better understand and manage standard formulary and specialty pharmaceutical and biologics usage. We bring together member, provider, and payer pharmacy case/care management staff with our own pharmacy and case/care management staff to facilitate the type of information sharing and decision-making that ultimately yields the best clinical and financial outcomes. Our tailored, world-class services for all plan sponsors — health plans, accountable care organizations (ACOs), state Medicaid programs, employer groups and unions — blend state-of-the-art technologies with experienced and talented professional teams to optimize your return on investment while enhancing your competitive stance in the market. For more information, visit www.rxadvance.com.

CONTACT

RxAdvance
Pooja Sammeta, 508-804-6900
psammeta@rxadvance.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • BioVectra与Keryx Biopharmaceuticals签署枸橼酸铁扩产协议
  • Eternity Healthcare Inc. Enters into Share Exchange Agreement with Guizho Tongren Healthy China Biotechnology Co. Ltd.
  • Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
  • Chi-Med Initiates Fruquintinib U.S. Clinical Trials
  • Orthocell Granted European Tendon Regeneration Patent